Bedside glue blepharorrhaphy for recalcitrant exposure keratopathy in immobilized patients.
CONCLUSIONS: Bedside glue blepharorrhaphy with tissue adhesive n-butyl-2-cyanoacrylate is a practical, economic, and effective procedure in the treatment of exposure keratopathy in immobilized patients.
Read the original here:
Bedside glue blepharorrhaphy for recalcitrant exposure keratopathy in immobilized patients.
Burn during a routine pterygium excision operation.
CONCLUSIONS: Surgeons should try to separate these three elements or eliminate any of them, in order to minimize or prevent such events. PMID: 18609490 [PubMed - indexed for MEDLINE] (Source: European Journal of Ophthalmology)
Originally posted here:
Burn during a routine pterygium excision operation.
Allergan Announces Intent To File New Drug Application For Bimatoprost As Novel Treatment To Stimulate Natural Eyelash Growth
Allergan, Inc. (NYSE:AGN) announced that it intends to file a New Drug Application by end of the third quarter of 2008 with the U.S. Food and Drug Administration (FDA) for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth.
Continue reading here:
Allergan Announces Intent To File New Drug Application For Bimatoprost As Novel Treatment To Stimulate Natural Eyelash Growth
Allergan Opens Up on Eyelash Drug
Allergan plans to seek FDA approval for a cosmetic drug to make eyelashes grow darker, thicker and longer. (Source: WSJ.com: Health)
Read the original post:
Allergan Opens Up on Eyelash Drug